Cargando…

Tumorigenic Conversion of a Rat Urothelial Cell Line by Human Polymorphonuclear Leukocytes Activated by Lipopolysaccharide

Chronic inflammation is a significant risk factor for the development of urinary bladder cancer. We have shown that inflammation induced by killed Escherichia coli and also by its lipopolysaccharide (LPS) strikingly enhances N‐methyl‐N‐nitrosourea (MNU)‐initiated rat bladder carcinogenesis. Aspirate...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamatani, Tetsuya, Turk, Patrick, Weitzman, Sigmund, Oyasu, Ryoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1999
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926149/
https://www.ncbi.nlm.nih.gov/pubmed/10543254
http://dx.doi.org/10.1111/j.1349-7006.1999.tb00823.x
_version_ 1783318848627277824
author Tamatani, Tetsuya
Turk, Patrick
Weitzman, Sigmund
Oyasu, Ryoichi
author_facet Tamatani, Tetsuya
Turk, Patrick
Weitzman, Sigmund
Oyasu, Ryoichi
author_sort Tamatani, Tetsuya
collection PubMed
description Chronic inflammation is a significant risk factor for the development of urinary bladder cancer. We have shown that inflammation induced by killed Escherichia coli and also by its lipopolysaccharide (LPS) strikingly enhances N‐methyl‐N‐nitrosourea (MNU)‐initiated rat bladder carcinogenesis. Aspirates from the bladder lumen contained a large quantity of hydrogen peroxide (H(2)O(2)) and several cytokines. In this study, we tested the hypothesis that reactive oxygen intermediates (ROI) released from activated polymorphonuclear leukocytes (PMN) are involved in inflammation‐associated bladder carcinogenesis. Using an immortalized nontumorigenic rat urothelial cell line, MYP3, we examined the effect of LPS‐activated PMN on malignant transformation. MYP3 cells pretreated with or without MNU were exposed daily to LPS‐activated PMN for one week and were then tested for growth in soft agar. In contrast to no colony formation by the parental cells, a varying number of colonies developed from cells treated with LPS‐activated PMN. Although combined treatment with MNU and PMN was most effective (P < 0.01), cells treated with LPS‐activated PMN alone also formed a small number of colonies. Addition of catalase, which decomposes H(2)O(2), and/or an antioxidant, α‐tocopherol, reduced the number of colonies induced by LPS‐activated PMN (P<0.05). Cells derived from colonies were tumorigenic in athymic nude mice. However, tumorigenicity in mice was greater with cells treated with both MNU and PMN than with cells treated with PMN alone. Our results suggest that ROI released from LPS‐activated PMN may be one of the mechanisms involved in the carcinogenesis associated with active urinary tract infection.
format Online
Article
Text
id pubmed-5926149
institution National Center for Biotechnology Information
language English
publishDate 1999
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-59261492018-05-11 Tumorigenic Conversion of a Rat Urothelial Cell Line by Human Polymorphonuclear Leukocytes Activated by Lipopolysaccharide Tamatani, Tetsuya Turk, Patrick Weitzman, Sigmund Oyasu, Ryoichi Jpn J Cancer Res Article Chronic inflammation is a significant risk factor for the development of urinary bladder cancer. We have shown that inflammation induced by killed Escherichia coli and also by its lipopolysaccharide (LPS) strikingly enhances N‐methyl‐N‐nitrosourea (MNU)‐initiated rat bladder carcinogenesis. Aspirates from the bladder lumen contained a large quantity of hydrogen peroxide (H(2)O(2)) and several cytokines. In this study, we tested the hypothesis that reactive oxygen intermediates (ROI) released from activated polymorphonuclear leukocytes (PMN) are involved in inflammation‐associated bladder carcinogenesis. Using an immortalized nontumorigenic rat urothelial cell line, MYP3, we examined the effect of LPS‐activated PMN on malignant transformation. MYP3 cells pretreated with or without MNU were exposed daily to LPS‐activated PMN for one week and were then tested for growth in soft agar. In contrast to no colony formation by the parental cells, a varying number of colonies developed from cells treated with LPS‐activated PMN. Although combined treatment with MNU and PMN was most effective (P < 0.01), cells treated with LPS‐activated PMN alone also formed a small number of colonies. Addition of catalase, which decomposes H(2)O(2), and/or an antioxidant, α‐tocopherol, reduced the number of colonies induced by LPS‐activated PMN (P<0.05). Cells derived from colonies were tumorigenic in athymic nude mice. However, tumorigenicity in mice was greater with cells treated with both MNU and PMN than with cells treated with PMN alone. Our results suggest that ROI released from LPS‐activated PMN may be one of the mechanisms involved in the carcinogenesis associated with active urinary tract infection. Blackwell Publishing Ltd 1999-08 /pmc/articles/PMC5926149/ /pubmed/10543254 http://dx.doi.org/10.1111/j.1349-7006.1999.tb00823.x Text en
spellingShingle Article
Tamatani, Tetsuya
Turk, Patrick
Weitzman, Sigmund
Oyasu, Ryoichi
Tumorigenic Conversion of a Rat Urothelial Cell Line by Human Polymorphonuclear Leukocytes Activated by Lipopolysaccharide
title Tumorigenic Conversion of a Rat Urothelial Cell Line by Human Polymorphonuclear Leukocytes Activated by Lipopolysaccharide
title_full Tumorigenic Conversion of a Rat Urothelial Cell Line by Human Polymorphonuclear Leukocytes Activated by Lipopolysaccharide
title_fullStr Tumorigenic Conversion of a Rat Urothelial Cell Line by Human Polymorphonuclear Leukocytes Activated by Lipopolysaccharide
title_full_unstemmed Tumorigenic Conversion of a Rat Urothelial Cell Line by Human Polymorphonuclear Leukocytes Activated by Lipopolysaccharide
title_short Tumorigenic Conversion of a Rat Urothelial Cell Line by Human Polymorphonuclear Leukocytes Activated by Lipopolysaccharide
title_sort tumorigenic conversion of a rat urothelial cell line by human polymorphonuclear leukocytes activated by lipopolysaccharide
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926149/
https://www.ncbi.nlm.nih.gov/pubmed/10543254
http://dx.doi.org/10.1111/j.1349-7006.1999.tb00823.x
work_keys_str_mv AT tamatanitetsuya tumorigenicconversionofaraturothelialcelllinebyhumanpolymorphonuclearleukocytesactivatedbylipopolysaccharide
AT turkpatrick tumorigenicconversionofaraturothelialcelllinebyhumanpolymorphonuclearleukocytesactivatedbylipopolysaccharide
AT weitzmansigmund tumorigenicconversionofaraturothelialcelllinebyhumanpolymorphonuclearleukocytesactivatedbylipopolysaccharide
AT oyasuryoichi tumorigenicconversionofaraturothelialcelllinebyhumanpolymorphonuclearleukocytesactivatedbylipopolysaccharide